Joshua Lehrer‐Graiwer

Rates of Behavior and Aging Specified by Mitochondrial Function During Development

Andrew Dillin, Ao‐Lin Hsu, Nuno Arantes-Oliveira et al. · Science · 2002 · 1.1K citations

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga et al. · New England Journal of Medicine · 2019 · 581 citations · Full text

Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events

Hamed Emami, Parmanand Singh, Megan H. MacNabb et al. · JACC. Cardiovascular imaging · 2015 · 249 citations · Full text

Obesity, Metabolic Syndrome, Cardiovascular Disease +8

A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease

Jo Howard, Claire Hemmaway, Paul Telfer et al. · Blood · 2019 · 110 citations · Full text

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial

Jo Howard, Kenneth I. Ataga, Robert C. Brown et al. · The Lancet Haematology · 2021 · 99 citations

Sickle Cell Disease, Pediatric Hematology, Long-term Follow-up Results +3